High insulin response can be your health ally, study says

Researchers at Sinai Health have unearthed vital information about the relationship between insulin levels after eating and long-term heart and metabolic health.

Rocket Pharmaceuticals’ RP-A601 receives FDA designations

RP-A601 is designed to treat plakophilin-2-related arrhythmogenic cardiomyopathy (PKP2-ACM). Credit: Africa Studio via Shutterstock.com. Rocket Pharmaceuticals has received fast track and orphan drug designations for

June 9, 2023

Rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction

You’re reading Part 2 of The War on Recovery, a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. Read

March 12, 2024

How lawmakers in Texas and Florida undermine covid vaccination efforts

Katherine Wells wants to urge her Lubbock, Texas, community to get vaccinated against covid-19. “That could really save people from severe illness,” said Wells, the

November 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.